Last reviewed · How we verify

NCT03794895

Prediction of Response to IUCD Associated Menorrhagia Using Doppler

Completed NA Last updated 7 January 2019
What this trial tests

NA trial testing Doppler in Women's Health: Amenorrhea/Dysmenorrhea in 156 participants. Completed in 1 May 2018.

Timeline
1 May 2017
Primary endpoint
1 May 2018
1 May 2018

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment156
Start date1 May 2017
Primary completion1 May 2018
Estimated completion1 May 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 35, female only, with Women's Health: Amenorrhea/Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Doppler

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03794895.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing